The slip
PARKINSON RECEIPTno. 10965
26 Oct 2026, 15:20 UTCdopamine neurons, braak
predictionRBP1 in dopamine neurons tracks Braak Lewy-body stage
registered7f5feb71c664df8c
discovery+0.59 p=0.096 n=9
replication-0.26 p=0.504 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.59, p 0.096)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTc987ae1b1ac8bf5918d53253…
follows ba6b27f17c4b…
Covered by the on-chain checkpoint of receipt 10974 (2026-10-26 15:38 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 10965: RBP1 in dopamine neurons, braak
- power
- full sample +0.10 (p 0.683, n 18), 95% CI -0.38 to +0.54. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.11 (p 0.652, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.11 (p 0.652, n 18). could be the mix.
- skeptic
- leave-one-out range +0.02 to +0.27, sign flips 0; without severely affected donors +0.10 (p 0.683, n 18). fragile.
- cell type
- strongest in microglia: -0.61 (p 0.0069, n 18) vs +0.10 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RBP1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up RBP1 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.50 p 0.076 (needs p < 2.0e-4)